A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production

Journal of Immunology

Volumn 193, Issue 12, 2014, Pages 5904-5913

  Kaku, Hiroaki ^a   Cheng, Kai Fan ^a   Al Abed, Yousef ^a   Rothstein, Thomas L ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; CD39 ANTIGEN; DEXTRAN SULFATE; INTERLEUKIN 10; APYRASE; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; IMMUNE DEFICIENCY; IN VITRO STUDY; MOUSE; NONHUMAN; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CHEMICALLY INDUCED; CYTOLOGY; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; MALE; METABOLISM; PERITONEAL CAVITY; PHENOTYPE;

5'-NUCLEOTIDASE; ADENOSINE; ANIMALS; ANTIGENS, CD; APYRASE; B-LYMPHOCYTE SUBSETS; COLITIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; IMMUNOMODULATION; IMMUNOPHENOTYPING; INTERLEUKIN-10; MALE; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PERITONEAL CAVITY; PHENOTYPE;

EID: 84916919314     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400336     Document Type: Article

References (68)

1. Buckley, C. D., D. W. Gilroy, C. N. Serhan, B. Stockinger, and P. P. Tak. 2013. The resolution of inflammation. Nat. Rev. Immunol. 13: 59-66.
2. Tabas, I., and C. K. Glass. 2013. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 339: 166-172.
3. Kayama, H., and K. Takeda. 2012. Regulation of intestinal homeostasis by innate and adaptive immunity. Int. Immunol. 24: 673-680.
4. Ohkura, N., Y. Kitagawa, and S. Sakaguchi. 2013. Development and maintenance of regulatory T cells. Immunity 38: 414-423.
5. Benoist, C., and D. Mathis. 2012. Treg cells, life history, and diversity. Cold Spring Harb. Perspect. Biol. 4: a007021.
6. Varol, C., E. Zigmond, and S. Jung. 2010. Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria. Nat. Rev. Immunol. 10: 415-426.
7. Coombes, J. L., and F. Powrie. 2008. Dendritic cells in intestinal immune regulation. Nat. Rev. Immunol. 8: 435-446.
8. DiLillo, D. J., T. Matsushita, and T. F. Tedder. 2010. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann. N. Y. Acad. Sci. 1183: 38-57.
9. Mauri, C., and P. A. Blair. 2010. Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol 6: 636-643.
10. Klinker, M. W., and S. K. Lundy. 2012. Multiple mechanisms of immune suppression by B lymphocytes. Mol. Med. 18: 123-137.
11. Bouaziz, J. D., K. Yanaba, and T. F. Tedder. 2008. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 224: 201-214.
12. Matsushita, T., K. Yanaba, J. D. Bouaziz, M. Fujimoto, and T. F. Tedder. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118: 3420-3430.
13. Xiu, Y., C. P. Wong, J. D. Bouaziz, Y. Hamaguchi, Y. Wang, S. M. Pop, R. M. Tisch, and T. F. Tedder. 2008. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J. Immunol. 180: 2863-2875.
14. Yanaba, K., J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto, and T. F. Tedder. 2008. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.
15. Mauri, C., and M. R. Ehrenstein. 2008. The 'short' history of regulatory B cells. Trends Immunol. 29: 34-40.
16. Lund, F. E. 2008. Cytokine-producing B lymphocytes-key regulators of immunity. Curr. Opin. Immunol. 20: 332-338.
17. Asadullah, K., W. Sterry, and H. D. Volk. 2003. Interleukin-10 therapy - review of a new approach. Pharmacol. Rev. 55: 241-269.
18. Katz, S. I., D. Parker, and J. L. Turk. 1974. B-cell suppression of delayed hypersensitivity reactions. Nature 251: 550-551.
19. Wolf, S. D., B. N. Dittel, F. Hardardottir, and C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278.
20. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
21. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501.
22. Evans, J. G., K. A. Chavez-Rueda, A. Eddaoudi, A. Meyer-Bahlburg, D. J. Rawlings, M. R. Ehrenstein, and C. Mauri. 2007. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 178: 7868-7878.
23. Gray, M., K. Miles, D. Salter, D. Gray, and J. Savill. 2007. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc. Natl. Acad. Sci. USA 104: 14080-14085.
24. Amu, S., S. P. Saunders, M. Kronenberg, N. E. Mangan, A. Atzberger, and P. G. Fallon. 2010. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J. Allergy Clin. Immunol. 125: 1114-1124 e1118.
25. Watanabe, R., M. Fujimoto, N. Ishiura, Y. Kuwano, H. Nakashima, N. Yazawa, H. Okochi, S. Sato, T. F. Tedder, and K. Tamaki. 2007. CD19 expression in B cells is important for suppression of contact hypersensitivity. Am. J. Pathol. 171: 560-570.
26. Mizoguchi, A., E. Mizoguchi, R. N. Smith, F. I. Preffer, and A. K. Bhan. 1997. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J. Exp. Med. 186: 1749-1756.
27. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230.
28. Yanaba, K., A. Yoshizaki, Y. Asano, T. Kadono, T. F. Tedder, and S. Sato. 2011. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am. J. Pathol. 178: 735-743.
29. Hussain, S., and T. L. Delovitch. 2007. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J. Immunol. 179: 7225-7232.
30. Haas, K. M., R. Watanabe, T. Matsushita, H. Nakashima, N. Ishiura, H. Okochi, M. Fujimoto, and T. F. Tedder. 2010. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J. Immunol. 184: 4789-4800.
31. Teichmann, L. L., M. Kashgarian, C. T. Weaver, A. Roers, W. Müller, and M. J. Shlomchik. 2012. B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Fas(lpr) mice. J. Immunol. 188: 678-685.
32. Ray, A., S. Basu, C. B. Williams, N. H. Salzman, and B. N. Dittel. 2012. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J. Immunol. 188: 3188-3198.
33. Miyara, M., and S. Sakaguchi. 2007. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13: 108-116.
34. Kobie, J. J., P. R. Shah, L. Yang, J. A. Rebhahn, D. J. Fowell, and T. R. Mosmann. 2006. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J. Immunol. 177: 6780-6786.
35. Deaglio, S., K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J. F. Chen, K. Enjyoji, J. Linden, M. Oukka, et al. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204: 1257-1265.
36. Chalmin, F., G. Mignot, M. Bruchard, A. Chevriaux, F. Végran, A. Hichami, S. Ladoire, V. Derangère, J. Vincent, D. Masson, et al. 2012. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. Immunity 36: 362-373.
37. Salmi, M., and S. Jalkanen. 2005. Cell-surface enzymes in control of leukocyte trafficking. Nat. Rev. Immunol. 5: 760-771.
38. Haskó, G., and B. N. Cronstein. 2004. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25: 33-39.
39. Friedman, D. J., B. M. Künzli, Y. I. A-Rahim, J. Sevigny, P. O. Berberat, K. Enjyoji, E. Csizmadia, H. Friess, and S. C. Robson. 2009. From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc. Natl. Acad. Sci. USA 106: 16788-16793.
40. Louis, N. A., A. M. Robinson, C. F. MacManus, J. Karhausen, M. Scully, and S. P. Colgan. 2008. Control of IFN-alphaA by CD73: implications for mucosal inflammation. J. Immunol. 180: 4246-4255.
41. Bynoe, M. S., A. T. Waickman, D. A. Mahamed, C. Mueller, J. H. Mills, and A. Czopik. 2012. CD73 is critical for the resolution of murine colonic inflammation. J. Biomed. Biotechnol. 2012: 260983.
42. Stall, A. M., S. Adams, L. A. Herzenberg, and A. B. Kantor. 1992. Characteristics and development of the murine B-1b (Ly-1 B sister) cell population. Ann. N. Y. Acad. Sci. 651: 33-43.
43. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46.
44. Cerutti, A., M. Cols, and I. Puga. 2013. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat. Rev. Immunol. 13: 118-132.
45. Zhong, X., J. R. Tumang, W. Gao, C. Bai, and T. L. Rothstein. 2007. PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding. Eur. J. Immunol. 37: 2405-2410.
46. Kaku, H., and T. L. Rothstein. 2010. Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter. Genes Immun. 11: 55-66.
47. - positive population of activated B1 cells expresses LIFR and responds to LIF. Front. Immunol. 2: 6.
48. Wang, H., D. M. Shin, S. Abbasi, S. Jain, A. L. Kovalchuk, N. Beaty, S. Chen, I. Gonzalez-Garcia, and H. C. Morse, III. 2012. Expression of plasma cell alloantigen 1 defines layered development of B-1a B-cell subsets with distinct innate-like functions. Proc. Natl. Acad. Sci. USA 109: 20077-20082.
49. Yamashita, Y., S. W. Hooker, H. Jiang, A. B. Laurent, R. Resta, K. Khare, A. Coe, P. W. Kincade, and L. F. Thompson. 1998. CD73 expression and fyn-dependent signaling on murine lymphocytes. Eur. J. Immunol. 28: 2981-2990.
50. Anderson, S. M., M. M. Tomayko, A. Ahuja, A. M. Haberman, and M. J. Shlomchik. 2007. New markers for murine memory B cells that define mutated and unmutated subsets. J. Exp. Med. 204: 2103-2114.
51. Tomayko, M. M., N. C. Steinel, S. M. Anderson, and M. J. Shlomchik. 2010. Cutting edge: Hierarchy of maturity of murine memory B cell subsets. J. Immunol. 185: 7146-7150.
52. Shimomura, Y., E. Mizoguchi, K. Sugimoto, R. Kibe, Y. Benno, A. Mizoguchi, and A. K. Bhan. 2008. Regulatory role of B-1 B cells in chronic colitis. Int. Immunol. 20: 729-737.
53. Zhang, X. 2013. Regulatory functions of innate-like B cells. Cell. Mol. Immunol. 10: 113-121.
54. Lampropoulou, V., E. Calderon-Gomez, T. Roch, P. Neves, P. Shen, U. Stervbo, P. Boudinot, S. M. Anderton, and S. Fillatreau. 2010. Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunol. Rev. 233: 146-161.
55. Sun, C. M., E. Deriaud, C. Leclerc, and R. Lo-Man. 2005. Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity 22: 467-477.
56. Moritoki, Y., W. Zhang, K. Tsuneyama, K. Yoshida, K. Wakabayashi, G. X. Yang, C. Bowlus, W. M. Ridgway, Y. Ueno, A. A. Ansari, et al. 2009. B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology 136: 1037-1047.
57. Kaku, H., and T. L. Rothstein. 2009. Fas apoptosis inhibitory molecule enhances CD40 signaling in B cells and augments the plasma cell compartment. J. Immunol. 183: 1667-1674.
58. Rothstein, T. L., and D. L. Kolber. 1988. Peritoneal B cells respond to phorbol esters in the absence of co-mitogen. J. Immunol. 140: 2880-2885.
59. Morris, D. L., and T. L. Rothstein. 1993. Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes. J. Exp. Med. 177: 857-861.
60. Ring, S., A. H. Enk, and K. Mahnke. 2011. Regulatory T cells from IL-10-deficient mice fail to suppress contact hypersensitivity reactions due to lack of adenosine production. J. Invest. Dermatol. 131: 1494-1502.
61. Kretschmer, K., A. Jungebloud, J. Stopkowicz, B. Stoermann, R. Hoffmann, and S. Weiss. 2003. Antibody repertoire and gene expression profile: implications for different developmental and functional traits of splenic and peritoneal B-1 lymphocytes. J. Immunol. 171: 1192-1201.
62. Yang, Y., E. E. Ghosn, L. E. Cole, T. V. Obukhanych, P. Sadate-Ngatchou, S. N. Vogel, L. A. Herzenberg, and L. A. Herzenberg. 2012. Antigen-specific antibody responses in B-1a and their relationship to natural immunity. Proc. Natl. Acad. Sci. USA 109: 5382-5387.
63. Yang, Y., E. E. Ghosn, L. E. Cole, T. V. Obukhanych, P. Sadate-Ngatchou, S. N. Vogel, L. A. Herzenberg, and L. A. Herzenberg. 2012. Antigen-specific memory in B-1a and its relationship to natural immunity. Proc. Natl. Acad. Sci. USA 109: 5388-5393.
64. Lazarowski, E. R. 2012. Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal. 8: 359-373.
65. Iwase, T., H. Shinji, A. Tajima, F. Sato, T. Tamura, T. Iwamoto, M. Yoneda, and Y. Mizunoe. 2010. Isolation and identification of ATP-secreting bacteria from mice and humans. J. Clin. Microbiol. 48: 1949-1951.
66. Karras, J. G., Z. Wang, L. Huo, R. G. Howard, D. A. Frank, and T. L. Rothstein. 1997. Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J. Exp. Med. 185: 1035-1042.
67. Saze, Z., P. J. Schuler, C. S. Hong, D. Cheng, E. K. Jackson, and T. L. Whiteside. 2013. Adenosine production by human B cells and B cell-mediated suppression of activated T cells. Blood 122: 9-18.
68. Griffin, D. O., N. E. Holodick, and T. L. Rothstein. 2011. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-. J. Exp. Med. 208: 67-80.